• <em>tRF-27</em> competitively Binds to G3BPs and Activates MTORC1 to Enhance HER2 Positive Breast Cancer Trastuzumab Tolerance
• <em>TSC2</em> loss in neural progenitor cells suppresses translation of ASD/NDD-associated transcripts in an mTORC1- and MNK1/2-reversible fashion
• 2024 Canadian Urological Association endorsement of an expert report: Kidney involvement in tuberous sclerosis complex
• A 20-year-old woman with chronic cough and dyspnea
• A 23-year bibliometric analysis of the development of global research on hereditary renal carcinoma
• A case of tuberous sclerosis complex revealed by epilepsy
• A Rare Case of Renal Angiomyolipoma and Polycystic Kidney Disease in a Patient with Tuberous Sclerosis
• A Triple Laser Combination Treatment for Facial Angiofibromata Management in Tuberous Sclerosis and Literature Review
• Aberrant TSC-Rheb axis in Oxytocin receptor+ cells mediate stress-induced anxiety
• Association of earlier surgery with improved postoperative language development in children with tuberous sclerosis complex
• Atypical noncontiguous TSC2/PKD1 gene deletions presenting as tuberous sclerosis/polycystic kidney disease contiguous gene syndrome
• Beyond Benign: A Case of Subependymal Giant Cell Astrocytomas Provoking Hydrocephalus in Tuberous Sclerosis Complex
• Case report: Liver PEComa after kidney transplantation in recipient with tuberous sclerosis complex
• Case Report: Patent ductus arteriosus with tuberous sclerosis complex
• Characteristics and Outcomes of Fetal Cardiac Rhabdomyoma With or Without mTOR Inhibitors, a Systematic Review and Meta-Analysis
• Circulating biomarkers of kidney angiomyolipoma and cysts in tuberous sclerosis complex patients
• Clinical and bioinformatics analysis of the relationship between LAMA3 DNA methylation expression and platinum resistance and prognosis in epithelial ovarian cancer
• Comparison of RNA-Sequencing Methods for Degraded RNA
• Complex Factors in Hydrocephalus Development in Tuberous Sclerosis Complex: A Case Report of Subependymal Giant Cell Astrocytoma
• Consensus panel recommendations for the optimization of EPIDIOLEX treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
• Correction: Diagnosis of tuberous sclerosis in the prenatal period: a retrospective study of 240 cases and review of the literature
• Cytoplasmic vacuolization and ectopic formation of perineuronal nets are characteristic pathologies of cytomegalic neurons in tuberous sclerosis
• Delayed diagnosis of tuberous sclerosis complex: unveiling low-level TSC2 mosaicism using targeted next-generation sequencing
• Development and internal validation of a clinical risk score to predict incident renal and pulmonary tumours in people with tuberous sclerosis complex
• Diffuse Cystic Lung Disease: A Clinical Guide to Recognition and Management
• Do germline genetic variants influence surgical outcomes in drug-resistant epilepsy?
• Do metabolic deficits contribute to sleep disruption in monogenic intellectual disability syndromes?
• Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial
• Early Subclinical Status Epilepticus May Contribute to Developmental Delays in Infants With Tuberous Sclerosis Complex
• Effectiveness and safety of liposomal rapamycin for the treatment of facial angiofibromas in tuberous sclerosis
• Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series
• Endovascular Treatment of a Bilateral, Ruptured Angiomyolipoma in a Patient With Tuberous Sclerosis Complex
• Eosinophilic Solid and Cystic Renal Cell Carcinoma-A Systematic Review and Meta-Analysis
• Epidemiology, Risk Factors, and Clinical Outcomes of AKI in Pediatric Hematopoietic Stem Cell Transplant Patients
• Evaluation of diagnostic accuracy of dermoscopy in some common hypopigmented skin diseases
• Exosomes originating from neural stem cells undergoing necroptosis participate in cellular communication by inducing TSC2 upregulation of recipient cells following spinal cord injury
• Experience of the first adult-focussed undiagnosed disease program in Australia (AHA-UDP): solving rare and puzzling genetic disorders is ageless
• Exploring Cardiovascular Involvement in Tuberous Sclerosis: Insights for Pediatric Clinicians
• Exudative Retinal Astrocytic Hamartomas and Papilledema in a Patient with Tuberous Sclerosis Complex and Subependymal Giant Cell Astrocytoma
• Fibrofatty involution of rhabdomyomas: a longitudinal series of cardiac MRI studies in a patient with possible tuberous sclerosis complex
• Genotypic and phenotypic analysis of Korean patients with tuberous sclerosis complex
• Giant Genital Mass: Unveiling a Unique Case of Folliculocystic and Collagen Hamartoma
• Giant renal angiomyolipomas with spontaneous hemorrhage associated with tuberous sclerosis complex during pregnancy
• Have epilepsy outcomes changed for children with tuberous sclerosis complex in Queensland, Australia?
• Hereditary Syndromes Associated with Pancreatic and Lung Neuroendocrine Tumors
• High-Resolution Proteomics Unravel a Native Functional Complex of Cav1.3, SK3, and Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels in Midbrain Dopaminergic Neurons
• Human TSC2 Mutant Cells Exhibit Aberrations in Early Neurodevelopment Accompanied by Changes in the DNA Methylome
• Hyperactive mTORC1 disrupts habenula function and light preference in zebrafish model of Tuberous sclerosis complex
• IL-37d suppresses Rheb-mTORC1 axis independently of TCS2 to alleviate alcoholic liver disease
• Impact of seizure onset zone and intracranial electroencephalography ictal characteristics on epilepsy surgery outcomes in tuberous sclerosis complex
• Incidence and Characteristics of Cerebellar Atrophy/Volume Loss in Children with Confirmed Diagnosis of Tuberous Sclerosis Complex
• Increased susceptibility to kainate-induced seizures in a mouse model of tuberous sclerosis complex: Importance of sex and circadian cycle
• Investigating the Prevalence, Gender Predilection, and Inheritance Patterns of Genodermatoses: A Tertiary Hospital Study
• Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program
• Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysis
• Loss of Tuberous Sclerosis Complex 2 confers inflammation via dysregulation of Nuclear factor kappa-light-chain-enhancer of activated B cells
• Loss of tumor suppressors promotes inflammatory tumor microenvironment and enhances LAG3+T cell mediated immune suppression
• Measures of youth e-cigarette use: strengths, weaknesses and recommendations
• miR-27a-3p promotes inflammatory response in infectious endophthalmitis via targeting TSC1
• MR-guided laser interstitial thermal therapy in the treatment of brain tumors and epilepsy
• mTOR aggravated CD4⁺ T cell pyroptosis by regulating the PPARγ-Nrf2 pathway in sepsis
• mTOR Deletion Alleviates CD4+ T-Cell Dysfunction in Sepsis through Reducing CTLA4 Accumulation Mediated by Rescuing Autophagy
• Multimodal Analysis of the Retinal Manifestations of Tuberous Sclerosis Complex: A Case Series
• Multimodal framework to resolve variants of uncertain significance in <em>TSC2</em>
• Multiparameter quantitative analyses of diagnostic cells in brain tissues from tuberous sclerosis complex
• Neonatal Cardiac Rhabdomyoma: A Single-Center Experience
• Neuropsychological profile in tuberous sclerosis complex: a study of clinical and cognitive variables in a cohort from Brazil
• Novel developments in the study of estrogen in the pathogenesis and therapeutic intervention of lymphangioleiomyomatosis
• Novel Stop-Gain TSC2 Gene Mutation in an Indian Child of Tuberous Sclerosis Complex
• Off-label use of cannabidiol in genetic epileptic and developmental encephalopathies: A case report
• Pathways to epilepsy surgery in children with tuberous sclerosis complex-associated epilepsy
• Pharmacokinetic variability of everolimus and impact of concomitant antiseizure medications in patients with tuberous sclerosis complex: A retrospective study of therapeutic drug monitoring data in Denmark and Norway
• PMEL is a predictive biomarker for mTORC1 inhibitor treatment of renal angiomyolipoma in tuberous sclerosis complex patients
• Portuguese Pancreatic Club Perspectives on Pancreatic Neuroendocrine Neoplasms: Diagnosis and Staging, Associated Genetic Syndromes and Particularities of Their Clinical Approach
• Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development
• Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? A case report and review of the literature
• Resting state EEG in young children with Tuberous Sclerosis Complex
• Sclerotic bone lesions: Think about tuberous sclerosis too
• Screening for biomarkers of tuberous sclerosis complex-associated epilepsy: a bioinformatics analysis
• Seizure-Related Falls and Near Falls in LGI1-IgG Autoimmune Encephalitis
• Spontaneous Hydropneumothorax After Pleurodesis in a Patient With Pulmonary Lymphangioleiomyomatosis With Associated Endometrial Cancer
• Subependymal Giant Cell Astrocytomas Without Tuberous Sclerosis: A Case Report on a Rare Medical Condition
• Subpial resection of epileptogenic tubers: operative nuances and lessons learned
• Successful use of Fenfluramine in super-refractory status epilepticus in a patient with tuberous sclerosis complex and Lennox-Gastaut syndrome
• TFE3-rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape
• The emotional burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy: A qualitative study in Japan
• The microbiota-dependent tryptophan metabolite alleviates high-fat diet-induced insulin resistance through the hepatic AhR/TSC2/mTORC1 axis
• The role of the TSC Alliance in advancing therapy development: a patient organization perspective
• The Spectrum of "TFEopathies" - Flipping the mTOR Switch in Renal Tumorigenesis
• Topical sirolimus in dermatology: a systematic review
• Transplacental therapy with sirolimus for non-tuberous sclerosis rhabdomyoma in fetus
• Treatment of Infantile Hemangiomas in Concomitant Tuberous Sclerosis Complex Should Prompt Evaluation for Cardiac Rhabdomyomas Prior to Initiation of Propranolol
• tRNA m¹A modification regulate HSC maintenance and self-renewal via mTORC1 signaling
• Tuberous Sclerosis Complex and the kidneys: what nephrologists need to know
• Uncovering hidden genetic variations: long-read sequencing reveals new insights into tuberous sclerosis complex
• Unusual adult-onset cardiac rhabdomyomas in tuberous sclerosis complex: a case report
• Unveiling Tuberous Sclerosis in a Diagnosed Patient With Systemic Lupus Erythematosus: A Rare Coincidence
• Uterine perivascular epithelioid cell tumors (PEComa) and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior
• Vitamin D in tuberous sclerosis complex-associated tumors
• Widespread service fragmentation for patients and families with tuberous sclerosis complex (TSC) in the Republic of Ireland